Emerging Technology in Cartilage Treatment

Faculty:

• Tom Minas

  Brigham and Women's Hospital, Boston, MA.

• Steve Cohen

  Rady Children's Hospital, San Diego, CA.

• Bert Mandelbaum

  Santa Monica Orthopedic Group, Santa Monica, CA.

• Jack Farr

  Cartilage Center of Indiana, Greenwood, IN.

Expiration: 05/19/2015

Location: Online

Requirements for successful completion: In order to receive credit, participants must view all audio-visual presentations and complete both the pre-test, post-test and evaluation form. Participants must score 100% on the activity post-test in order to receive credit. There are no pre-requisites for this activity. Course attendance verification forms are provided upon successful completion of the post-test and evaluation form. No partial credit will be given.

Target Audience: Physicians, residents and trainees, fellows, nurses, surgical techs, physical therapists, and other members of the allied health community whose scope of practice encompasses Orthopaedics.

Course Description: In this live webinar, expert Sports Medicine, Adult Reconstruction, Shoulder/Elbow will present optimal operable techniques and treatment options to address Emerging Technology in Cartilage Treatment . The webinar features time for interactive audience discussion and surgical case based scenarios.

Learning Objectives: Upon completion of this activity, participants should be better able to discuss:

1. Discuss differences between matrices and microfracture in the treatment of cartilage
2. Discuss the use of biologic cement injections for the prevention of knee arthritis
3. Discuss advancements in PRP for the treatment of osteoarthritis
4. Discuss the use of stem cell therapies as a cartilage treatment

Credits: This lecture qualifies for 2 CME credit hours.

Cost: $0.0

Accreditation Statement: This activity has been planned and implemented in accordance with the Essential Areas and policies of the Accreditation Council for Continuing Medical Education through the joint sponsorship of the The International Institute for Continuing Medical Education, Inc and VuMedi. The International Institute for Continuing Medical Education, Inc is accredited by the Accreditation Council for Continuing Medical Education to provide medical education to physicians.

Designation Statement: The International Institute for Continuing Medical Education, Inc designates this live activity for a maximum of 2 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Faculty Disclosures: Faculty Disclosures/Conflict of Interest Policy\nIn accordance with ACCME requirements, The International Institute for Continuing Medical Education, Inc, has a conflict of interest policy that requires faculty to disclose relevant financial relationships related to the content of their presentations/materials. Any potential conflicts are resolved so that presentations are evidence-based and scientifically balanced. The relationships were reviewed by The International Institute for Continuing Medical Education, Inc. and conflicts of interest were resolved prior to the activity.

Dr. Bert Mandelbaum discloses the following relevant financial relationships with a commercial interest: AJSM, Cartilage: Editorial or governing board, Arthrex, Inc: IP royalties, Exactech, Inc: Paid consultant, Genzyme, zimmer, smith and nephew, arthrex, alter G, game ready: Paid consultant, ICRS: Board or committee member, Johnson & Johnson: Paid consultant

Dr. Tom Minas discloses the following relevant financial relationships with a commercial interest: Conformis: IP royalties; Stock or stock Options, Elsevier: Publishing royalties, financial or material support, Vericel: Paid consultant

Dr. Steve Cohen discloses the following relevant financial relationships with a commercial interest: Arthrex, IncMajor League Baseball: Research support, CONMED Linvatec: Paid consultant, Slack, INC: Publishing royalties, financial or material support, Zimmer: IP royalties; Paid consultant; Paid presenter or speaker

Dr. Jack Farr discloses the following relevant financial relationships with a commercial interest: Advanced Biosurfaces, NuOrtho Surgical, Inc.: Paid consultant, American Journal of Sports Medicine: Editorial or governing board, Arthrex, Inc: Paid consultant; Paid presenter or speaker, Arthrocare: Paid presenter or speaker; Research support, BioRegeneration Technologies, NuTech Medical: Paid consultant, Cartilage Research Foundation, Inc., Treasurer: Board or committee member, CartilageJournal of Knee Surgery: Editorial or governing board, Ceterix Orthopaedics: Paid consultant, Clinical Orthopaedics and Related Research: Editorial or governing board, Depuy: Research support, DePuy, A Johnson & Johnson Company: Paid consultant, Depuy/Mitek: Research support, Genzyme a Sanofi Company: Paid consultant; Research support, Histogenics: Research support, ICRS Regulatory & Industry Liason Committee- Chairman: Board or committee member, Johnson & Johnson Companies(Depuy), Arthrex, Inc:: IP royalties, Knee Creations, LLC: Paid consultant, Knee Creations,Inc. NuTech Medical: Research support, Knee Surgery, Sports Traumatology, Arthroscopy: Editorial or governing board, Medshape, Inc: Paid presenter or speaker; Stock or stock Options, Mitek: Paid consultant, Moximed, Inc.: Paid presenter or speaker; Research support, Moximed, Inc.,Medshape, Inc, Arthrocare: Paid consultant, Osiris Therapeutics, Inc.: Paid presenter or speaker, Patellofemoral Foundation, Board of Directors: Board or committee member, Patellofemoral International Patellofemoral Study Group: Board or committee member, RTi Biologics, Inc.: Paid consultant; Research support, SBM Inc.: Paid consultant, Schwartz Biomedical, LLC.: Paid consultant, Springer: Publishing royalties, financial or material support, Stryker: Paid consultant, The Knee: Editorial or governing board, Thieme Medical Publishers, Inc: Publishing royalties, financial or material support, Zimmer: Paid consultant; Research support

Faculty Disclosures of Unlabeled Use: The faculty of this educational activity may include discussions of products or devices that are not currently labeled for use by the FDA. Faculty members have been advised to disclose to the audience any reference to an unlabeled or investigational use. No endorsement of unapproved products or uses is made or implied by coverage of these products or uses in our reports. No responsibility is taken for errors or omissions in reports. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications and warnings.

Dr. Bert Mandelbaum does not intend to discuss off-label uses of drugs, mechanical devices, biologics, or diagnostics approved by the FDA for use in the United States.

Dr. Tom Minas does not intend to discuss off-label uses of drugs, mechanical devices, biologics, or diagnostics approved by the FDA for use in the United States.

Dr. Steve Cohen does not intend to discuss off-label uses of drugs, mechanical devices, biologics, or diagnostics approved by the FDA for use in the United States.

Dr. Jack Farr does not intend to discuss off-label uses of drugs, mechanical devices, biologics, or diagnostics approved by the FDA for use in the United States.

Commercial Support: No commercial support was received for this activity.

Software Requirements: VuMedi Webinars supports the following web browsers (with enabled JavaScript™): Internet Explorer® versions 6.0, 7.0, 8.0, Mozilla Firefox versions 1.0, 2.0, 3.0, and Safari for Mac. Certain educational activities may require additional software to view multimedia, presentation or printable versions of their content. That software may be: Adobe Acrobat®, Adobe® Flash Player, Microsoft® Office PowerPoint, and Microsoft® Office Word.These activities will be marked as such and will provide links to the required software.

Copyright: Any and/or all materials are for the exclusive use of the faculty and participants of the live activity. Any copying, duplicating or reproducing of any and/or all materials by electronic, mechanical or other means for any purpose other than this enduring activity is strictly prohibited without prior written consent of the author of those materials.

Policy on Privacy and Confidentiality: For more information regarding VuMedi's Policy on Privacy and Confidentiality, please visit http://www.vumedi.com/pages/privacy/

To Contact our Accredited Provider: 6438 US Hwy 11
Springville, AL 35146
Phone: (205) 467-0290
Fax: (205) 467-0195
email: iicmemail@gmail.com

For questions regarding this activity, please contact VuMedi: cme@vumedi.com